AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
DROSPIRENONE; ETHINYLESTRADIOL in Zimbabwe
2 products registered with MCAZ β 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CONTREZ TABLET, COATED; ORAL | 2023/21.2.1/6523 | INNOVATA PHARMACEUTICALS | active | 5 Dec 2028 |
| YASTRA 20 TABLET, COATED; ORAL | 2023/21.2.1/6419 | COSPHARM INVESTMENTS (PTY) LTD | active | 29 Jun 2028 |
DROSPIRENONE; ETHINYLESTRADIOL β MCAZ Registration Details
MCAZ (Zimbabwe) has 2 registered products containing DROSPIRENONE; ETHINYLESTRADIOL, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DROSPIRENONE; ETHINYLESTRADIOL registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.